I've Watched 50+ GLP-1 Patients Walk Into My Clinic Celebrating a Number on the Scale. Here's What Their Bloodwork Told Me.

She was forty-six years old, three months into her GLP-1 prescription, down thirty-two pounds, and in tears on my exam table.

"I should be happy," she told me. "I've been trying to lose this weight for fifteen years. Why do I feel like I'm dying?"

I looked at her intake form. She had come in for fatigue. Brain fog. Hair she was pulling out of her shower drain in handfuls. Nails that had started splitting. Sleep that had deteriorated over eight weeks. Irritability she described as "not recognizing myself." And a number on the scale that, for the first time in her adult life, was going where she'd always wanted it to.

I pulled her bloodwork. Her Vitamin D was 18 ng/mL — deficient. Her ferritin had dropped from 82 to 34. Her magnesium was on the floor. Her B12, which had been fine six months earlier, was now in the lower range of normal. Her albumin — a rough proxy for protein status — had dropped meaningfully. She wasn't winning. She was starving herself of the nutrients her body runs on, and her GLP-1 medication was so effective at suppressing her appetite that she hadn't noticed.

I wrote her a list of supplements that afternoon. Eleven of them. She came back two weeks later with a photograph of her kitchen counter and a look on her face that said: you've got to be kidding me.

Eleven bottles. Forty-plus pills a day. Hundreds of dollars a month. And by week three, she had already stopped taking half of them. Not because they weren't working — she hadn't been on them long enough to know — but because the system I had given her was unsustainable for a woman who had already been prescribed a drug to help her eat less.

The irony wasn't lost on me. I had spent fifteen years counseling patients about the chaos of overmedication. And here I was, adding to the pile.

That was eighteen months ago. In the months since, I have seen this exact pattern — down to the bloodwork and the emotional break — in more than fifty patients on GLP-1 medications. This article is what I've learned, what the research says, and the one supplement I now recommend in place of the ridiculous stack I used to prescribe.

GLP-1 receptor agonists — the class of drugs that includes the popular weight-loss and diabetes medications now in tens of millions of medicine cabinets — work by mimicking a gut hormone called glucagon-like peptide-1. They slow gastric emptying, increase the sensation of fullness, and modulate glucose metabolism. For patients with type 2 diabetes, obesity, or insulin resistance, the results can be genuinely life-changing.

What the medication does not do — and this is what nobody is putting on the prescription insert with appropriate prominence — is ensure that the dramatically reduced food intake the drug enables still delivers the forty-plus nutrients a human body requires to function. A 1,200-calorie day looks the same on a scale whether it contains dense nutrition or subsists on protein bars and iced coffee. But the cellular reality is radically different.

The dirty secret no one in the GLP-1 marketing machine is discussing: reducing appetite without systematically replacing the nutrients that reduced food intake stops delivering is a recipe for accelerated nutrient depletion. This isn't theoretical. This is what I watch on bloodwork every single week.

This is the one I am most concerned about clinically, and the one most of my patients have never been warned about.

Research published in multiple journals now estimates that up to 40% of the weight patients lose on GLP-1 medications is lean body mass — muscle, not fat. In practical terms: a patient who loses 40 pounds on a GLP-1 medication may have lost up to 16 pounds of muscle.

The protective intervention — supported by the research literature and, frankly, by basic physiology — is adequate amino acid intake paired with resistance training. IM8 Essentials Pro delivers an amino complex at 1,580mg per serving, plus electrolytes and CoQ10 that support the cellular machinery muscle uses to maintain itself. It is not a substitute for protein at meals. It is a foundation that helps the meals you do eat do more work.

I want to give you the actual list, because I think the specificity matters. These are the deficiencies I have seen appear, worsen, or accelerate in the GLP-1 patients in my practice — not hypotheticals, actual labs:

A 2026 Cambridge University study I've cited in my podcast found that patients on GLP-1 medications receive essentially zero structured nutritional guidance from their prescribers — fewer than 15% reported having been given any specific nutrient monitoring or supplementation plan. This is a gap the medical system is going to need to close. Until it does, individual patients and individual clinicians — like me — are closing it one at a time.

Hair coming out in clumps. Nails splitting at the tips. Skin that looks older by three or four years in three or four months. These are not vanity concerns. These are signals.

When the body is running a nutrient deficit, it triages. Hair follicles, nail beds, and skin cells are metabolically expensive tissues that the body will deprioritise when there isn't enough raw material to go around. If you are losing hair noticeably three months into a GLP-1 prescription, your body is not being vain — it is conserving resources.

Roughly 40% of GLP-1 users experience meaningful gut symptoms — nausea, bloating, constipation, or the opposite — at some point in their prescription. This is a documented side effect of the medication's mechanism (slowed gastric emptying), and it's the single most common reason patients discontinue.

What most prescribers don't address: the reduced food intake that accompanies a GLP-1 prescription is itself disruptive to the gut microbiome. Your gut bacteria feed on the prebiotic fibres in the food you eat. When you eat less food, they get less to eat. When you eat less variety of plant foods, their diversity collapses. When the microbiome thins out, the gut-brain axis becomes noisier, the immune function you outsource to the gut weakens, and the gastrointestinal symptoms the medication is already causing get worse.

In IM8's 12-week randomised, controlled clinical trial (NCT06655597), 85% of participants felt better digestion. In my GLP-1 patient subset, the percentage is higher — though my sample is smaller and uncontrolled, so I say that with appropriate humility.

I trained in allergy, immunology, and integrative medicine. Mood and cognition are not my primary board certification — but they are the one clinical area I spend the most time on in practice, because they are the symptoms most patients actually present with when something systemic is wrong.

Mood symptoms — irritability, low motivation, emotional fragility, a flat grey feeling — are showing up in GLP-1 patients at rates that warrant attention. When a patient's Vitamin D is at 18 ng/mL, her B12 is low-normal, her magnesium is in the basement, and her active folate is depleted, mood is going to suffer. These four nutrients are foundational to neurotransmitter synthesis and nervous system regulation.

When I sit down with a GLP-1 patient who is describing mood and cognitive complaints, I want to know her bloodwork before I consider anything else. In nine out of ten cases, the intervention that moves the needle first is correcting the nutritional substrate. Medication adjustment, if needed, comes after — not before.

I want to share what I have been seeing on follow-up labs in the patients I have started on IM8 Essentials Pro as part of their GLP-1 protocol. I'm going to be careful about the framing because my clinical observation is not a randomised trial. But the directional data is consistent enough that I feel obliged to share it.

In my clinical observation with GLP-1 patients specifically, the energy and gut improvements are the first and most reliably reported. Hair and skin changes follow, usually by week 8–10. Mood and cognition shifts happen on a more variable timeline — depending heavily on the depth of the initial deficit.

I am a physician. I do not recommend products from brands I have not scrutinised. When I first reviewed IM8 Essentials Pro, I ran it against the separate-supplement stack I had been prescribing to patients. Here is what the comparison looked like.

What I also found, running the labels side by side: IM8 uses clinical-dose bioactive forms across the board. P5P, Methylcobalamin, Quatrefolic, Magnesium Bisglycinate, Vitamin D3 from vegan lichen, Vitamin K2 as MK-7. These are the forms I have been recommending to patients for years. Most pharmacy-shelf multivitamins use cheaper forms (pyridoxine HCl, cyanocobalamin, folic acid, magnesium oxide) that a meaningful fraction of the population cannot convert or absorb efficiently.

This is what I mean by expensive urine. You're paying for the idea of nutrition, not the dose. IM8 is not expensive urine. The formula is dose-transparent, bioactive-form-first, and clinically tested.

I have spent this article making a clinical case. I owe you some limits.

This is supplementation. It is not pharmacology. Do the conversation with your physician properly.

This is the first all-in-one supplement I have recommended to my clinical practice in fifteen years. I do not say that lightly.

IM8 Essentials Pro addresses the specific nutrient deficits I have watched accumulate on my GLP-1 patients' bloodwork — muscle-supporting amino acids, gut-rebuilding pre/pro/postbiotics, bioactive B vitamins for mood and cognition, clinical-dose Vitamin D3 and K2 for bone and cardiovascular integrity, magnesium bisglycinate for sleep and stress, MSM and Vitamin C for the collagen production boosting complex, and the anti-inflammatory complex that quiets the systemic low-grade inflammation that accompanies rapid weight loss in most patients.

It is not a substitute for the medication. It is not a substitute for adequate protein and resistance training. It is not a cure. What it is, in my clinical judgement, is the foundational layer the GLP-1 prescribing system is failing to build underneath the medication.

I serve on the IM8 Scientific Advisory Board. That relationship began because I was already recommending the product in practice — not the other way around. My discount code for readers of this essay is AMY.

If you are on a GLP-1 medication and you have any of the symptoms I described in Section 01 — fatigue that isn't improving, hair loss, low mood, irritability, gut symptoms, brain fog — I would encourage you to have a conversation with your prescribing physician about nutritional monitoring. If you have already been through that conversation and want a foundational supplement that covers the deficits patients on this class of medication reliably develop, IM8 Essentials Pro is, in my current clinical opinion, the most complete option I have reviewed.

Worst case: you use the up to 90-day money-back guarantee. Best case: your labs look better in twelve weeks than they did in twelve years. I have seen the second outcome more times than I expected when I started tracking it.

— Dr. Amy Shah, MD

References

1. San Francisco Research Institute. (2024). IM8 Clinical Trial. ClinicalTrials.gov: NCT06655597.
2. Wilding, J.P.H., et al. (2021). Weight loss composition with GLP-1 receptor agonists. New England Journal of Medicine, 384(11), 989-1002.
3. Cambridge University. (2026). Nutritional guidance gaps in GLP-1 prescribing patterns.
4. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487-497.
5. Firoz, M., & Graber, M. (2001). Bioavailability of US commercial magnesium preparations. Magnesium Research, 14(4), 257-262.
6. Scaglione, F., & Panzavolta, G. (2014). Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica, 44(5), 480-488.
7. Hausenblas, H.A., et al. (2013). Saffron and mood: a meta-analysis. Journal of Integrative Medicine, 11(6), 377-383.